A carregar...

Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin or Vancomycin for a Skin Infection in the Outpatient Setting

OBJECTIVE: Hospital admission is a key cost driver among patients with skin and soft tissue infections (SSTI). Data suggest that many SSTI patients are hospitalized unnecessarily and can be managed effectively and safely in an outpatient setting at a substantially lower cost. Oritavancin (ORI) is a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Lodise, Thomas P, Palazzolo, Christina, Reksc, Kerry, Packnett, Elizabeth, Redell, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902011/
https://ncbi.nlm.nih.gov/pubmed/31844636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz475
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!